Carlyle Group Inc. - VERA THERAPEUTICS INC ownership

VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 71 filers reported holding VERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Carlyle Group Inc. ownership history of VERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,688,342
-49.2%
1,438,155
-40.5%
0.85%
-38.2%
Q2 2023$38,766,065
+69.4%
2,416,837
-18.4%
1.38%
+102.2%
Q1 2023$22,882,5862,960,2310.68%
Other shareholders
VERA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,372,428$26,170,0413.38%
COMMODORE CAPITAL LP 2,824,029$21,914,4653.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,002,257$7,747,4472.16%
Sofinnova Investments, Inc. 3,467,156$26,905,1311.72%
Altium Capital Management LP 286,000$2,219,3601.23%
Eversept Partners, LP 1,788,529$13,878,9850.97%
SECTORAL ASSET MANAGEMENT INC 600,300$4,658,3280.90%
Octagon Capital Advisors LP 795,000$6,169,2000.89%
Carlyle Group Inc. 2,960,231$22,882,5860.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,300,000$10,088,0000.22%
View complete list of VERA THERAPEUTICS INC shareholders